In July 2023, the FDA approved the first nonprescription daily contraceptive pill. Opill® (norgesterl) is now available for purchase nationwide.

Over-the-counter availability of Opill® may reduce barriers to access by allowing individuals to obtain an oral contraceptive without the need to first see a health care provider. It may also help reduce the number of unintended pregnancies and their potential negative impacts.

Opill® contains one hormone, progestin, which makes it harder for sperm to reach an egg, thins the lining of the uterus and can sometimes prevent ovulation. This type of birth control, known as the “mini pill,” is taken at the same time each day. When used as directed, the effectiveness of Opill® can be as high as 98%.

Click here for more information about Opill®.